← Leaderboards
Michael P McDermott
Upstate Medical University
$21,453,394
Attributed
$30,571,664
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,071,664 · 9
FDA$500,000 · 1
By mechanism
R01$13,501,937 · 1
U01$11,043,897 · 3
R33$1,591,423 · 1
P50$1,494,821 · 1
R61$1,145,753 · 1
U10$968,391 · 1
Top collaborators
- Rabi Tawil8 shared
- Andras Perl7 shared
- Ashkan Ertefaie5 shared
- Charles Stanley Venuto5 shared
- Daniel J. Wallace5 shared
- Robert H Dworkin1 shared
- Robert R Edwards1 shared
- Jennifer Gewandter1 shared
Most similar at Upstate Medical University
Same institution · by research overlap
- Andras Perl$17,954,100
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsClinical TrialsEnrollmentRandomizedDosageData ManagementFollow-UpBaseSample SizeSafetyUniversitiesDesignProceduresVisitWithdrawalGenerationsBiometryClinically RelevantPrimary OutcomeMonitorReportingDouble-Blind MethodParticipantStandardization
Grant awards (37)
SLE Treatment with N-acetylcysteine$1,310,215
U01 · FY2025 · AR
Experimental Neurotherapeutics Training Program$420,442
T32 · FY2025 · NS
SLE Treatment with N-acetylcysteine$1,437,594
U01 · FY2024 · AR
Advancing Personalized Medicine in PD Using Harmonized Multi-Site Clinical Data$472,189
R33 · FY2024 · NS
SLE Treatment with N-acetylcysteine$1,447,294
U01 · FY2023 · AR
Advancing personalized medicine in PD using harmonized multi-site clinical data$562,637
R33 · FY2023 · NS
Advancing personalized medicine in PD using harmonized multi-site clinical data$556,597
R33 · FY2022 · NS
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center$301,398
P50 · FY2022 · NS · contact PI
SLE Treatment with N-acetylcysteine$1,386,367
U01 · FY2021 · AR
Advancing personalized medicine in PD using harmonized multi-site clinical data$631,099
R61 · FY2021 · NS
Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Public-Private Partnership$500,000
U01 · FY2021 · FD
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center$303,684
P50 · FY2021 · NS · contact PI
SLE Treatment with N-acetylcysteine$1,500,000
U01 · FY2020 · AR
Advancing personalized medicine in PD using harmonized multi-site clinical data$514,654
R61 · FY2020 · NS
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center$303,611
P50 · FY2020 · NS · contact PI
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center$313,905
P50 · FY2019 · NS · contact PI
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$204,029
U01 · FY2019 · NS · contact PI
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center$272,223
P50 · FY2018 · NS · contact PI
Coordinating-Center$204,954
U10 · FY2018 · EY · contact PI
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$203,615
U01 · FY2018 · NS · contact PI
Coordinating-Center$763,437
U10 · FY2017 · EY · contact PI
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$213,275
U01 · FY2017 · NS · contact PI
Treatment of Systemic Lupus Erythematosus (SLE) with N-acetylcysteine (NAC)$202,500
R34 · FY2017 · AR
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$204,232
U01 · FY2016 · NS · contact PI
Treatment of Systemic Lupus Erythematosus (SLE) with N-acetylcysteine (NAC)$202,500
R34 · FY2016 · AR
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$550,000
U01 · FY2015 · NS · contact PI
Coordination and Statistics for Coenzyme Q10 in Huntington's Disease$786,137
R01 · FY2014 · NS · contact PI
Coordination and Statistics for Coenzyme Q10 in Huntington's Disease$2,300,345
R01 · FY2013 · NS · contact PI
Coordination and Statistics for Coenzyme Q10 in Huntington's Disease$2,300,345
R01 · FY2012 · NS · contact PI
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$611,306
U01 · FY2012 · NS · contact PI
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$573,331
U01 · FY2011 · NS · contact PI
Coordination and Statistics for CoQ10 in HD [2CARE]$1,996,155
R01 · FY2010 · NS · contact PI
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD$902,639
U01 · FY2010 · NS · contact PI
Coordination and Statistics for CoQ10 in HD [2CARE]$1,654,265
R01 · FY2009 · NS · contact PI
Coordination and Statistics for CoQ10 in HD [2CARE]$1,559,458
R01 · FY2008 · NS · contact PI
Coordination and Statistics for CoQ10 in HD [2CARE]$1,592,975
R01 · FY2007 · NS · contact PI
Coordination and Statistics for CoQ10 in HD [2CARE]$1,312,257
R01 · FY2005 · NS